Elevated Anticardiolipin Antibody Titer Is a Stroke Risk Factor in a Multiethnic Population Independent of Isotype or Degree of Positivity | Zendy

Stanley Tuhrim | Zendy; Jacob H. Rand | Zendy; Xiao-Xuan Wu | Zendy; Jesse Weinberger | Zendy; Deborah Horowitz | Zendy; Martin E. Goldman | Zendy; James Godbold | Zendy

Open Access

Elevated Anticardiolipin Antibody Titer Is a Stroke Risk Factor in a Multiethnic Population Independent of Isotype or Degree of Positivity

Author(s) -

Stanley Tuhrim,

Jacob H. Rand,

Xiao-Xuan Wu,

Jesse Weinberger,

Deborah Horowitz,

Martin E. Goldman,

James Godbold

Publication year - 1999

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.30.8.1561

Subject(s) - medicine , stroke (engine) , odds ratio , titer , population , risk factor , gastroenterology , immunology , atrial fibrillation , myocardial infarction , antibody , mechanical engineering , environmental health , engineering

Previous studies have produced conflicting results regarding the putative association between anticardiolipin antibodies (aCL) and infarction in the general stroke population. These inconsistencies may be a function of sample size and methodological differences among the studies. The purpose of the present study, the largest case-control study of this issue to date, was to assess aCL status as an independent risk factor for ischemic stroke in a multiethnic, urban population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research